MARKSANS vs SYRMA: Stock Comparison
Head-to-head financial and trading comparison between Marksans Pharma Limited (MARKSANS) and Syrma SGS Technology Limited (SYRMA) in the Cross-Sector Peers sector.
MARKSANS
NSE: MARKSANSSYRMA
NSE: SYRMAKey Metrics Comparison Table
| Metric | MARKSANS | SYRMA | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹309.10 | ₹1,719.90 | — |
| 1-Year Price Return | +74.73% | +78.53% | SYRMA (3.80% higher) |
| 52-Week High | ₹347.60 | ₹1,782.90 | — |
| 52-Week Low | ₹176.77 | ₹958.95 | — |
| 30-Day Annualized Volatility | 42.37% | 57.1% | MARKSANS (Steadier) |
| 30-Day Average Daily Volume | 2,394,723 | 2,317,100 | MARKSANS (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MARKSANS and SYRMA, which stock gave better returns over the last year?
SYRMA has outperformed MARKSANS over the past 12 months with a gain of 78.53% compared to 74.73%.
Which stock is less volatile: MARKSANS or SYRMA?
MARKSANS demonstrated lower price volatility (42.37% annualized) compared to SYRMA (57.1%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MARKSANS vs SYRMA?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MARKSANS and SYRMA direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.